Laser Iridotomy Versus Surgical Iridectomy in Early Angle Closure
Laser Peripheral Iridotomy Versus Surgical Peripheral Iridectomy in Early Angle Closure:a Randomized Clinical Trial
1 other identifier
interventional
120
1 country
1
Brief Summary
This is a randomized controlled clinical trial to compare laser peripheral iridotomy(LPI) and surgical peripheral iridectomy. Subjects of primary angle closure suspect, primary angle closure will be randomized to undergo LPI or SPI. Subjects are proposed to be followed up for 3 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 6, 2011
CompletedFirst Posted
Study publicly available on registry
November 9, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedNovember 9, 2011
November 1, 2011
3 years
November 6, 2011
November 8, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
intraocular pressure
3 years
Secondary Outcomes (1)
Angle assessment parameters
3 years
Study Arms (2)
PACS
EXPERIMENTALprimary angle closure suspects
PAC
EXPERIMENTALprimary angle closure
Interventions
Surgical Iridectomy is now widely used in our clinical.
alternative choice to surgical iridectomy
Eligibility Criteria
You may qualify if:
- more than 50 years old
- Diagnosis of either: Primary angle closure suspects, Primary angle closure in need of laser iridotomy or surgical iridectomy
- Able to give Informed concent
You may not qualify if:
- Ophthalmic diseases other than glaucoma and cataract
- pseudophakic or aphakic patients
- inability to attend regular follow-up assessment or to give informed written consent
- Secondary causes of angle closure e.g. subluxed lens, uveitis, trauma and neovascular glaucoma
- Participating in another study
- monocular patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ZhongShan Ophthalmic Center
Guangzhou, Guangdong, 510060, China
Study Officials
- STUDY DIRECTOR
Zhang X Lan, MD
Sun Yat-sen University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- student
Study Record Dates
First Submitted
November 6, 2011
First Posted
November 9, 2011
Study Start
August 1, 2009
Primary Completion
August 1, 2012
Study Completion
August 1, 2012
Last Updated
November 9, 2011
Record last verified: 2011-11